222

APTABIO THERAPEUTICS INC.

No trades
See on Supercharts

293780 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. It offers selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company was founded by Su-Jin Lee on July 24, 2009 and is headquartered in Yongin, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

293780 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company